Skip to content
Research Article Open access CC BY 3.0

Relation of Sirtuin 1 Gene Polymorphisms with Lipid Profile in Hemodialysis Patients

Yasser Elghobashy, Safaa Tayel, Abeer ALrefai, Said Khamis, Hany Elbarbary

Biotechnology Journal International · pp. 932–945 · Published 14 Aug 2014

10.9734/BBJ/2014/12326

Abstract

Relation of Sirtuin 1 Gene Polymorphisms with Lipid Profile in Hemodialysis Patients Very little is known about the genetic variation of SIRT 1 and its effects on energy homeostasis in humans. Mammalian SIRT1deacetylates a host of target proteins that are important for apoptosis, the cell cycle, circadian rhythms, mitochondrial function and metabolism. In particular, much current research focuses on the impact of SIRT1 in glucose homeostasis, lipid metabolism and energy balance. Objective: To study the relationship of sirtuin 1 gene polymorphisms with lipids profile in hemodialysis patients. Subjects and Methods: This study included 70 Egyptian subjects (45 patients on hemodialysis and 25 age and gender matched healthy control group). The genotyping of SIRT1 rs7895833 in the promoter region, rs7069102 in intron 4, and rs2273773 in exon 5 was performed using polymerase chain reaction with confronting two-pair primers assay (CTPP). Serum TC, TG, HDLc, LDLc, fasting glucose, urea and creatinine were measured by standard colorimetric methods. Results: The patients had higher diastolic and systolic BP (P<0.001), fasting blood glucose (P<0.001), TC (P<0.001), TG (P=0.006), LDLc (P=0.004), urea (P<0.001) and creatinine (P<0.001). Males and female patients differ according to cause of hemodialysis (P= 0.02) and serum creatinine (P=0.007). Control subjects of sirtuin1 rs7895833 showed significant A allele compared with patients (46% vs. 27.78% P= 0.04) while C allele of sirtuin1 rs7069102 not differ between groups (P>0.05). Sirtuin 1 rs2273773, patients showed significant lower frequency of C allele compared with control (26.67% vs.44% P= 0.04,). Conclusion: Significant association of SIRT1 rs7895833 and rs2273773 polymorphisms with dyslipidemia and blood pressure may modulate disease course in hemodialysis.

Sirtuin 1 lipids CTPP hemodialysis

References (39)

  1. 1 Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α [DOI]
  2. 2 Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase [DOI]
  3. 3 Extending Healthy Life Span—From Yeast to Humans [DOI]
  4. 4 Mammalian Sirtuins: Biological Insights and Disease Relevance [DOI]
  5. 5 Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ [DOI]
  6. 6 The Sir2 Family of Protein Deacetylases [DOI]
  7. 7 Phylogenetic Classification of Prokaryotic and Eukaryotic Sir2-like Proteins [DOI]
  8. 8 PGC-1α: a key regulator of energy metabolism [DOI]
  9. 9 Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation [DOI]
  10. 10 Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1 [DOI]
  11. 11 Metabolic adaptations through the PGC‐1α and SIRT1 pathways [DOI]
  12. 12 Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1 [DOI]
  13. 13 Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials [DOI]
  14. 14 SIRT1 and insulin resistance [DOI]
  15. 15 United States Renal Data System 2007 Annual Data Report Abstract [DOI]
  16. 16 Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO [DOI]
  17. 17 FOXO1 Represses Peroxisome Proliferator-activated Receptor-γ1 and -γ2 Gene Promoters in Primary Adipocytes [DOI]
  18. 18 SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity [DOI]
  19. 19 Endothelial Sirtuin 1 Deficiency Perpetrates Nephrosclerosis through Downregulation of Matrix Metalloproteinase-14 [DOI]
  20. 20 The risk of atherosclerosis in patients with chronic kidney disease [DOI]
  21. 21 SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases [DOI]
  22. 22 Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes [DOI]
  23. 23 Abnormalities of Lipoprotein Metabolism in Patients with the Nephrotic Syndrome [DOI]
  24. 24 Molecular mechanisms of lipid disorders in nephrotic syndrome [DOI]
  25. 25 Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation [DOI]
  26. 26 The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity [DOI]
  27. 27 Impact of Dyslipidemia in End-Stage Renal Disease [DOI]
  28. 28 Sirtuins and Their Relevance to the Kidney [DOI]
  29. 29 Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis [DOI]
  30. 30 Association of SIRT1 gene variation with visceral obesity [DOI]
  31. 31 Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease [DOI]
  32. 32 SIRTUIN 1 Gene Polymorphisms are Associated With Cholesterol Metabolism and Coronary Artery Calcification in Japanese Hemodialysis Patients [DOI]
  33. 33 Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression [DOI]
  34. 34 Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study [DOI]
  35. 35 Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome [DOI]
  36. 36 Pattern of lipid profile in patients on maintenance hemodialysis.
  37. 37 Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome [DOI]
  38. 38 Lipid profile in pre-dialysis chronic kidney disease patients attending University of Maiduguri Teaching Hospital, Maiduguri-Nigeria.
  39. 39 Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP [DOI]

Cited by 4

In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins

A. Kuryłowicz · International Journal of Molecular Sciences · 2016

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

2

Page views

0

PDF downloads

0

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.